During a Case-Based Roundtable® event, Daniel J. George, MD, discusses how often community oncology participants see patients ...
Insurance firms in South Korea shift focus to guaranteed products for stable profits Insurers in South Korea prioritize ...
New research by Oregon Health & Science University scientists has uncovered multiple factors to improve gene delivery to the ...
GI-102 is under clinical development by GI Innovation and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success rate (PTSR) ...
In an extremely rare case, an unnamed 69-year-old man who had cirrhosis and liver cancer underwent a liver transplant and ...
Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...
In an extremely rare case, an unnamed 69-year-old man who had cirrhosis and liver cancer underwent a liver transplant and ...
The new year brings renewed hope for the parents of an eight-year-old Franksville boy who learned in 2024 his kidneys are failing and he's going to need a transplant. A ...
As we age, our bodies undergo various physiological changes that necessitate a proactive approach to health management.
The safety profile of ICI for the treatment of malignancies in patients diagnosed with autoimmune and cholestatic liver disease (AILD ... esophageal cancer (n=1), small cell lung cancer (n=1), renal ...
Manmeet Ahluwalia, MD, MBA, FASCO, discusses the prevalence of brain metastases in patients with primary renal cell carcinoma.
Patients on hemodialysis diagnosed with cancer have a 3-year survival rate similar to that of individuals with cancer in the general population.